Royalty Pharma plc RPRX | NASDAQ

$32.62 $0.14 | 0.43%

Next Earnings: May 08, 2025

Company Overview:

Market Cap: $14.14B
PE Ratio: 17.08
52-Week Range: $24.05 - $34.20
Dividend Yield (FWD): 2.71% ($0.88)

4.9 Year Performance Metrics:

Total Return (with DRIP): -18.86% (-4.17% / yr)
Total Return (no DRIP): -18.92% (-4.19% / yr)
Share Price: -27.01%
Dividend Increase: 46.67
RPRX 4.9-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

RPRX Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
RPRX Dividend CAGR:1Y: 4.76%2Y: 4.88%5Y: 7.96%10Y: N/A
Share Price
RPRX Price CAGR:1Y: 15.71%2Y: -4.12%5Y: -6.10%10Y: -3.10%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

RPRX Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - RPRX
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - RPRX
14-Day FREE Trial Get Full Access Now!

RPRX Earnings, Revenue, Cash & Debt, Shares Outstaning:

RPRX - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
RPRX - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
RPRX - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
RPRX - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
RPRX - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
RPRX - Cash & Debt
14-Day FREE Trial Get Full Access Now!
RPRX - Revenue
14-Day FREE Trial Get Full Access Now!
RPRX Revenue CAGR:1Y: -0.34%2Y: 2.47%5Y: 5.36%10Y: 0.00%
RPRX - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
RPRX EPS CAGR:1Y: -68.47%2Y: 50.12%5Y: -38.60%10Y: 0.00%
RPRX - Net Income
14-Day FREE Trial Get Full Access Now!
RPRX Net Income CAGR:1Y: -57.92%2Y: 53.00%5Y: -31.90%10Y: 0.00%
RPRX - EBITDA
14-Day FREE Trial Get Full Access Now!
RPRX EBITDA CAGR:1Y: -46.28%2Y: 46.35%5Y: -22.92%10Y: 0.00%
RPRX - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
RPRX Free Cash Flow CAGR:1Y: 430.29%2Y: 57.78%5Y: 179.49%10Y: 0.00%
RPRX - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
RPRX Free Cash Flow / Share CAGR:1Y: 429.51%2Y: 56.99%5Y: 166.70%10Y: 0.00%
RPRX - Gross Profit
14-Day FREE Trial Get Full Access Now!
RPRX Gross Profit CAGR:1Y: 14.34%2Y: 0.00%5Y: 0.00%10Y: 0.00%
RPRX - Expenses
14-Day FREE Trial Get Full Access Now!
RPRX Expenses CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: 0.00%
RPRX - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
RPRX Shares Outstanding CAGR:1Y: 32.73%2Y: 15.65%5Y: 10.85%10Y: 0.00%
RPRX - Share Buybacks
14-Day FREE Trial Get Full Access Now!
RPRX Share Buybacks CAGR:1Y: 74.20%2Y: 0.00%5Y: 0.00%10Y: 0.00%
RPRX - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
RPRX Stock-Based Comp CAGR:1Y: -14.91%2Y: -5.10%5Y: 0.00%10Y: 0.00%
RPRX - Dividends
14-Day FREE Trial Get Full Access Now!
RPRX Dividend CAGR:1Y: 4.76%2Y: 4.88%5Y: 7.96%10Y: N/A
RPRX - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
RPRX Revenue CAGR:1Y: -0.34%2Y: 2.47%5Y: 5.36%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

RPRX - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RPRX Actual Revenue CAGR:1Y: -0.34%2Y: 2.47%5Y: 5.36%10Y: 0.00%
RPRX - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RPRX Actual EPS CAGR:1Y: -68.47%2Y: 50.12%5Y: -38.60%10Y: 0.00%
RPRX - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RPRX Actual Net Income CAGR:1Y: -57.92%2Y: 53.00%5Y: -31.90%10Y: 0.00%
RPRX - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
RPRX Actual EBITDA CAGR:1Y: -46.28%2Y: 46.35%5Y: -22.92%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

RPRX - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
RPRX Net Profit Margin CAGR:1Y: -57.78%2Y: 52.47%5Y: -35.37%10Y: 0.00%
RPRX - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
RPRX Gross Profit Margin CAGR:1Y: 14.73%2Y: 0.50%5Y: 0.00%10Y: 0.00%
RPRX - Price to Earnings
14-Day FREE Trial Get Full Access Now!
RPRX - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
RPRX - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
RPRX - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

RPRX Dividends Info:

Annual Dividend: $0.88
Forward Yield: 2.7%
Ex-Dividend Date: 2025-05-16
Lifetime Dividens / Share: $4.04

RPRX Dividend History: Dates, Payments & Yield list

Below is a schedule of all RPRX dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
05/16/202506/10/2025$0.2202.65%2.71%$32.48
02/21/202503/10/2025$0.2202.54%2.63%$33.42
02/20/202503/10/2025$0.2202.78%2.88%$30.58
11/15/202412/10/2024$0.2103.27%3.27%$25.70
08/16/202409/13/2024$0.2103.05%3.09%$27.17
05/16/202406/14/2024$0.2102.94%3.01%$27.88
02/15/202403/15/2024$0.2102.7%2.8%$30.03
11/16/202312/15/2023$0.2003.02%3.02%$26.53
08/17/202309/15/2023$0.2002.7%2.73%$29.27
05/18/202306/15/2023$0.2002.32%2.38%$33.63
02/15/202303/15/2023$0.2002.04%2.12%$37.69
11/17/202212/15/2022$0.1901.8%1.8%$42.33
08/18/202209/15/2022$0.1901.68%1.72%$44.17
05/19/202206/15/2022$0.1901.81%1.91%$39.78
02/17/202203/15/2022$0.1901.76%1.92%$39.68
11/18/202112/15/2021$0.1701.62%1.62%$41.98
08/19/202109/15/2021$0.1701.7%1.75%$38.88
05/19/202106/15/2021$0.1701.6%1.7%$40.01
02/18/202103/15/2021$0.1701.01%1.46%$46.49
11/19/202012/15/2020$0.1500.72%1.45%$41.48
09/14/202009/30/2020$0.1500.38%1.51%$39.82

Projected Future Returns & Dividends for RPRX

Based on past 4.9-year performance, here are RPRX growth metrics:

Share price CAGR of -6.22%
Dividend CAGR of +8.5%

Using RPRX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

RPRX (DRIP)RPRX - No DRIP
Current Price$32.48$32.48
Start Shares307.88307.88
Start Value$10,000$10,000
  
After 10 years:
Final Share Count541.54307.88
Dividends Payment$0.50$0.50
Annual Dividends$1,078$613
Yield on cost10.78%6.13%
Share Price$18.22$18.22
Total Dividends$5,212$4,020
Final Value$9,865$9,628

Estimated Future Value + Dividends - RPRX

NOTE: Above numbers are our estimate based on RPRX's Dividend and Price CAGR over past 4.9 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Royalty Pharma plc (RPRX) had its IPO on , and is trader on NASDAQ stock exchange.

RPRX website: https://www.royaltypharma.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial